Accelerator, the venture-backed biotech startup machine, has made its name over the past decade as a hotspot for financing life sciences companies in Seattle with big dreams and potential. Now it’s considering expanding its model for starting biotech companies in other life science clusters around the world, including New York.
Plans are still in the exploratory stage, but the idea is that Accelerator would remain headquartered in Seattle and build a network of satellite labs in four or five other locations around the world, says Carl Weissman, the co-founder and CEO of Accelerator. Accelerator’s existing venture backers, and some potential new investors, have expressed interest in a more far-reaching version of Accelerator, Weissman says.
{iframe}http://www.xconomy.com/seattle/2012/06/01/accelerator-looks-to-expand-with-an-eye-on-the-big-apple/?utm_source=Xconomy&utm_campaign=6a23760ed7-NEWSLETTER_ALL_STORIES&utm_medium=email{/iframe}